Home

Tempête de neige Écureuil déclaration puma biotech stock price Expiré poids Maxime

PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence

Buy Puma Biotechnology Inc stock & View ($PBYI) Share Price on eToro.
Buy Puma Biotechnology Inc stock & View ($PBYI) Share Price on eToro.

PBYI Stock Price and Chart — NASDAQ:PBYI — TradingView
PBYI Stock Price and Chart — NASDAQ:PBYI — TradingView

Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space  (NASDAQ:PBYI) | Seeking Alpha
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha

Here's Why Puma Biotechnology Inc. Is Getting Beaten Down Today | The  Motley Fool
Here's Why Puma Biotechnology Inc. Is Getting Beaten Down Today | The Motley Fool

Puma (PBYI): Recent Rally Looks Overdone, Unsupported With Fundamentals |  Seeking Alpha
Puma (PBYI): Recent Rally Looks Overdone, Unsupported With Fundamentals | Seeking Alpha

PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's

Puma Biotech's (PBYI) Nerlynx Aids Top Line, Overdependence a Woe
Puma Biotech's (PBYI) Nerlynx Aids Top Line, Overdependence a Woe

These 2 Biotech Stocks Cratered in 2015 -- Is 1 Now a Buy? | The Motley Fool
These 2 Biotech Stocks Cratered in 2015 -- Is 1 Now a Buy? | The Motley Fool

PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener

Puma's (PBYI) Earnings and Revenues Beat Estimates in Q1
Puma's (PBYI) Earnings and Revenues Beat Estimates in Q1

Why Shares in Puma Biotechnology Inc. Are Plunging | The Motley Fool
Why Shares in Puma Biotechnology Inc. Are Plunging | The Motley Fool

Puma (PBYI): Recent Rally Looks Overdone, Unsupported With Fundamentals |  Seeking Alpha
Puma (PBYI): Recent Rally Looks Overdone, Unsupported With Fundamentals | Seeking Alpha

Great week for Puma Biotechnology, Inc. (NASDAQ:PBYI) institutional  investors after losing 32% over the previous year - Simply Wall St News
Great week for Puma Biotechnology, Inc. (NASDAQ:PBYI) institutional investors after losing 32% over the previous year - Simply Wall St News

SEC charges former Puma biotech exec with $1.1 million in insider trading
SEC charges former Puma biotech exec with $1.1 million in insider trading

Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space  (NASDAQ:PBYI) | Seeking Alpha
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha

Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A  Buy-In Opportunity - Market Exclusive
Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity - Market Exclusive

Puma Biotechnology
Puma Biotechnology

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule  5635(c)(4)
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

2 Drug Stocks Near Key Technical Levels After ASCO
2 Drug Stocks Near Key Technical Levels After ASCO

Breakeven On The Horizon For Puma Biotechnology, Inc. (NASDAQ:PBYI) | Nasdaq
Breakeven On The Horizon For Puma Biotechnology, Inc. (NASDAQ:PBYI) | Nasdaq

Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales - TheStreet
Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales - TheStreet

Puma Biotechnology
Puma Biotechnology

Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat

Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors  think so | Fierce Pharma
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma